Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$118,906,214
+$17,251,441 QoQ
Shares Held
468,190
+12.6% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
2.00%
of 13F equity value
Holder Rank
#271
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CRAWFORD INVESTMENT COUNSEL INC holds $569,205,568 across 10 Drug Manufacturers - General names. JNJ ranks #3 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
818,972 | $206,086,114 | |
| 2 | AZN |
Astrazeneca PLC
|
708,224 | $134,293,434 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
468,190 | $118,906,214 | |
| 4 | PFE |
Pfizer Inc
|
1,735,218 | $41,784,049 | |
| 5 | GSK |
GSK plc
|
634,985 | $33,285,913 | |
| 6 | MRK |
Merck & Co., Inc.
|
144,979 | $18,629,801 | |
| 7 | LLY |
ELI LILLY & Co
|
8,977 | $10,767,284 | |
| 8 | AMGN |
Amgen Inc
|
7,793 | $2,822,001 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $118,906,214 | 468,190 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $101,654,773 | 415,868 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $89,778,014 | 433,815 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $80,100,512 | 431,995 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $65,602,917 | 429,479 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $71,662,614 | 432,119 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $63,207,038 | 437,056 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $72,620,706 | 448,110 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $64,778,258 | 443,201 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $98,078,274 | 620,003 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $94,974,095 | 605,934 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $95,158,577 | 610,970 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $100,965,379 | 609,989 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $94,336,255 | 608,621 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $109,360,128 | 619,078 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $102,142,473 | 625,260 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $109,514,084 | 616,946 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $114,689,432 | 647,122 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $111,377,176 | 651,062 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $103,203,668 | 639,032 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $104,434,122 | 633,933 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $98,627,092 | 600,104 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $93,131,975 | 591,765 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $88,074,430 | 591,580 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $82,605,640 | 587,397 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $76,244,620 | 581,443 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||